Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

MODERNA US, INC. PRINCETON 08540 JIB

UEI: SLED_FB24DC6B1D49C418

MODERNA US, INC. PRINCETON 08540 JIB is a federal contractor, registered under UEI SLED_FB24DC6B1D49C418. It has been awarded $86,895,530 across 2 federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Nac Pharmaceuticals (36E797) and Other agencies (1 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

SLED_FB24DC6B1D49C418

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Nac Pharmaceuticals (36E797)$86.7M99.7%

Other agencies (1 agencies, <0.5% each)$225.0K0.3%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$86.9M100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in MODERNA US, INC. PRINCETON 08540 JIB's top NAICS codes and agencies

Medical Disinfectant Supply – Povidone-Iodine SolutionThe contract seeks the supply of a 7.5% povidone-iodine cleansing solution in 1-gallon bottles, specifically for use by the Department of Defense’s Medical Supply Chain under the Food and Drug Administration and United States Pharmacopeia standards. All products must meet stringent pharmaceutical specifications to ensure safety and efficacy in medical settings, with delivery targeted to the designated performance location in San Diego, CA, 92113-3650. The solicitation is structured as a subcontract under NAICS code 325412, indicating classification within the pharmaceutical preparation industry. Responses must be submitted by the deadline of July 27, 2026, with the opportunity posted on July 20, 2026. The contracting entity is the MEDICAL SUPPLY CHAIN PHARM FSA, operating under the broader authority of the Department of Defense. While no set-aside program is specified, the procurement is accessible to qualified subcontractors capable of meeting the required regulatory and logistical demands. Further information and submission details are available through the official DIBBS portal link provided.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – Famotidine Tablets (Prescription Medication)The contract involves the supply and delivery of one box of Famotidine Tablets, identified by NDC 00904-5529-87 and NSN 6505016823166, to the USNS EARL WARREN (T-AO 207) through a Fleet Post Office address. This is a pharmaceutical procurement under a subcontract, classified under NAICS code 325412 for pharmaceutical preparation manufacturing, and is managed by the Defense Logistics Agency on behalf of the Department of Defense. The contract was posted on July 20, 2026, and is directed toward fulfilling a specific medical need aboard the vessel, emphasizing timely and precise delivery of a prescription medication to support onboard healthcare requirements. The point of performance is linked to the ship's mobile location via FPO channel, and the transaction is tracked through the DLA’s procurement system under contract number SPE2DX25D8022 and delivery order SPE2D926F7452.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – Epinephrine InjectionA single pack of Epinephrine Injection, identified by NSN 6505016682549 and NDC 42023-0159-25, is being supplied under a subcontract awarded by the Defense Logistics Agency on behalf of the Department of Defense. The delivery is designated for USS CHARLESTON LCS 18 at FPO AP 96694 with FOB destination terms, meaning the vendor assumes all costs and risks until the product reaches the designated military location. This procurement falls under NAICS code 325412, which classifies it within pharmaceutical and medicinal manufacturing. The contract was posted on July 20, 2026, and the transaction is tracked through DLA’s contract system with the referenced award and delivery identifiers. No set-aside provisions or specific small business preferences are indicated for this solicitation.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply and DeliveryThe contract obligates the supply and delivery of one bottle of Raltegravir Potassium tablets, identified by NSN 6505016218317 and NDC 00006-0227-61, to the USS CHARLESTON LCS 18 at a designated FOB destination. The delivery must adhere to strict pharmaceutical standards, including compliant packaging and labeling that meet all regulatory and military requirements. The shipment must be traceable throughout its transit and issued under DPAS priority rating to ensure timely and prioritized handling within the Department of Defense logistics framework. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical and botanical product manufacturing, and is administered by the Defense Logistics Agency on behalf of the Department of Defense. The award was posted on July 20, 2026, and references the contract number SPE2DX25D9822 with delivery order SPE2D226F3070 to support mission-critical medical needs aboard the vessel.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – FLUOROMETHOLONE OPH (Topical Ophthalmic Steroid)The contract involves the manufacture and supply of eight bottles of Fluorometholone Ophthalmic Suspension, identified by NSN 6505010153995, to meet stringent FDA current Good Manufacturing Practices and military-specific labeling requirements. The product is a topical ophthalmic steroid intended for military use and must comply with all regulatory and technical standards mandated for defense medical supplies. Delivery is designated for Fort Bragg, North Carolina, ensuring alignment with operational medical needs at the installation. This action is classified as a subcontract under the North American Industry Classification System code 325412, which corresponds to pharmaceutical and medicine manufacturing. The contract is managed by the Defense Logistics Agency on behalf of the Department of Defense, reflecting its role in securing critical pharmaceutical inventory for military personnel. The posting date of July 20, 2026, indicates this is a future procurement, likely planned for procurement cycle alignment or inventory replenishment. The contract details are accessible through the DIBBS system, and while no specific point of contact or funding details are provided, adherence to military logistics protocols and pharmaceutical compliance is mandatory.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply of Labetalol Hydrochloride InjectionThe contract entails the manufacture and supply of four units of Labetalol Hydrochloride Injection USP, 5 mg/mL in 40 mL vials, strictly adhering to FDA regulations, current Good Manufacturing Practices, and specialized military labeling standards. The product is identified by NSN 6505012579990 and is intended for use within the Department of Defense’s medical supply chain, ensuring compatibility with military pharmacopeial and logistical requirements. Production and delivery must meet all quality assurance benchmarks mandated for federal medical procurement, with full compliance documented to support inventory integration and battlefield readiness. Subcontracted under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, the solicitation was posted on July 20, 2026, with responses due by July 27, 2026. The place of performance is designated as Fort Stewart, Georgia, with a ZIP code of 31314-5185, indicating the primary logistics and distribution hub for the delivered product. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, and the official request can be accessed via the DIBBS portal, underscoring the transaction’s direct alignment with military pharmaceutical procurement protocols.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – Lidocaine Hydrochloride InjectionThe contract entails the supply and delivery of Lidocaine Hydrochloride Injection, identified by NSN 6505016140068 and NDC 63323-0485-27, to a U.S. military vessel operating overseas under FOB destination terms, meaning the supplier bears all costs and risks until the product reaches the designated vessel. The product must comply fully with FDA regulatory standards and Defense Logistics Agency specifications to ensure safety, efficacy, and compatibility with military medical protocols. Manufactured under NAICS code 325412, which classifies it as pharmaceutical preparation production, the contract is structured as a subcontract awarded by the Department of Defense through the Defense Logistics Agency, with performance tied to overseas operational needs. The agreement was posted on July 20, 2026, and is tracked via contract number SPE2DX25D9822 with delivery reference SPE2D226F3073, indicating precise accountability for logistics and inventory control within the military supply chain.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – Diazepam TabletsThe contract entails the supply and delivery of one bottle of Diazepam Tablets, 5 mg, to meet specific National Stock Number and National Drug Code requirements for DLA Troop Support under a subcontract agreement. The delivery must be completed by July 20, 2026, ensuring compliance with all pharmaceutical and logistical standards mandated by the Defense Logistics Agency. The product falls under NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is destined for use within the Department of Defense supply chain. Although no solicitation number or point of contact is provided, the contract is accessible through the DIBBS system using the referenced award and delivery identifiers. Performance location and organizational details remain unspecified, but the obligation is firm and tied to federal procurement protocols.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – ENOXAPARIN INJECTION (NDC 00075-0622-80)The contract involves the supply and delivery of ENOXAPARIN INJECTION with NDC 00075-0622-80, specifically for military medical use under stringent packaging, labeling, and shipping standards established by the Defense Logistics Agency. All materials must fully comply with DLA’s regulatory and logistical requirements to ensure readiness, safety, and traceability within the Department of Defense’s medical supply chain. The product is designated under NAICS code 325412, indicating it is manufactured within the pharmaceutical and medicine manufacturing sector. This subcontract is posted under the DLA’s procurement system and is tied to contract SPE2DX25D9822 with delivery document SPE2D226F3072, with an official posting date of July 20, 2026. The performance location and point of contact details are not specified, but fulfillment is expected to meet the agency’s operational tempo and distribution protocols across military medical facilities. The agreement emphasizes adherence to federal pharmaceutical guidelines and DLA’s end-to-end logistics framework to support force health protection and medical readiness.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply of Sumatriptan Succinate InjectionThe contract entails the supply and delivery of 4,000 kilograms of FDA-approved Sumatriptan Succinate Injection, specifically aligned with designated NDC and NSN codes for use by the U.S. military. The product must meet stringent regulatory and specification requirements to ensure compatibility with military medical protocols and storage standards. This subcontract is issued under the Defense Logistics Agency on behalf of the Department of Defense, with the NAICS code 325412 indicating classification within pharmaceutical manufacturing. The award is tied to a specific contract number and delivery reference, indicating an established procurement process within the DIBBS system. While details regarding delivery location and point of contact are not provided, the contract is structured for fulfillment aligned with defense logistical needs, emphasizing compliance, traceability, and readiness for deployment in military healthcare settings.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Medical Chemical Formulation and ManufacturingThe contract involves the manufacture of a modified 0.125 percent sodium hypochlorite solution, known as Dakins Solution Quarter Strength, packaged in 480 mL bottles. The scope includes full formulation development, rigorous quality control protocols, batch-by-batch testing to ensure consistency and safety, and strict compliance with medical-grade standards to meet regulatory requirements for clinical use. All production activities must adhere to guidelines ensuring sterility, stability, and purity, as the final product is intended for medical applications requiring precise chemical concentrations and contamination-free packaging. The contract is classified as a subcontract under NAICS code 325412 for pharmaceutical and medicine manufacturing, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. It was posted on July 20, 2026, with a response deadline of July 27, 2026, and the performance location is not specified, implying flexibility in manufacturing site selection as long as compliance and delivery standards are met. The solicitation is accessible through the DIBBS platform, and while no set-aside provisions or point of contact information is provided, bidders are expected to demonstrate proven capability in producing pharmaceutical-grade chemical solutions with validated quality systems and documented adherence to medical manufacturing regulations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – Fluoxetine CapsulesThe contract pertains to the manufacture and supply of four bottles of Fluoxetine Capsules, identified by NSN 6505013974313 and NDC 50111-0647-01, with strict adherence to both FDA and Department of Defense standards. This is a subcontract under the Defense Logistics Agency, a component of the Department of Defense, and is classified under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing. The solicitation was posted on July 20, 2026, and the delivery is linked to award SPE2DX25D9900 with delivery order SPE2DP26F7758. The product must meet all applicable regulatory and military specifications to ensure compatibility with DoD medical requirements. The place of performance and point of contact details are not specified, but the contractual obligations are tied directly to DLA’s pharmaceutical procurement processes and must be fulfilled in alignment with federal supply chain protocols.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Medical Specimen Kit Manufacturing and AssemblyThe contract pertains to the manufacture and assembly of fecal specimen collection kits, each containing a 10 mL screw-cap vial with a blue cap and gasket, pre-filled with Cary-Blair transport media, and constructed entirely without latex. The kits must be designed for ambient storage, eliminating the need for refrigeration during transport and storage. All components must meet stringent medical standards for safety and functionality, ensuring specimen integrity throughout the collection and transport process. The work involves full-scale production and assembly, including quality control protocols to guarantee consistency and compliance with biomedical specifications. This is a subcontract opportunity under the NAICS code 325412, issued by the Department of Defense through its Medical Supply Chain MD Surg FSF division. The solicitation was posted on July 20, 2026, with a response deadline of July 27, 2026. The place of performance and specific delivery location are not detailed, but the contract will require adherence to DoD procurement standards. Interested parties must submit proposals via the DIBBS platform before the deadline, and the successful contractor will be responsible for delivering fully compliant kits in agreed volumes to support medical logistics operations.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – Hydrocortisone Vale (NSN 6505012240177)The contract entails the supply and delivery of 5,000 treatment units of Hydrocortisone Vale, a pharmaceutical product designated by the military NSN 6505012240177, to Fort Bragg, North Carolina. The item must fully comply with all applicable Department of Defense packaging, labeling, and technical specifications required for military pharmaceutical logistics. The agreement is structured as a subcontract under the broader procurement efforts of the Defense Logistics Agency, operating on behalf of the Department of Defense, with the NAICS code 325412 indicating manufacturing of other pharmaceutical and medicinal products. Delivery is scheduled in alignment with military supply chain timelines, and the contract is linked to an active award recorded in the DIBBS system with the contract number SPE2DX25D9900 and delivery order SPE2DP26F7762. The product is intended for use in military medical facilities and must meet stringent quality and regulatory standards inherent to federal healthcare procurement.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Supply of Ringer’s Injection, Lactated (NSN 6505014623022)The contract entails the procurement of Ringer’s Injection, Lactated, designated by NSN 6505014623022, to be supplied in full compliance with FDA regulations and packaged and labeled according to Defense Logistics Agency standards. This subcontract, issued under the NAICS code 325412 for pharmaceutical and biological product manufacturing, is managed by the Department of Defense through the Defense Logistics Agency and is intended to support critical medical supply needs within the defense sector. The product must meet exacting quality and regulatory benchmarks to ensure safety and efficacy for military and related medical use. The solicitation was posted on July 20, 2026, and is linked to the award contract SPE2DX25D8022 with delivery order SPE2D926F7457. While the specific place of performance and point of contact are not detailed, the requirement emphasizes adherence to DLA’s packaging and labeling protocols, indicating a standardized logistical process across defense channels. The contract does not specify a set-aside classification, suggesting it is open to general competition among qualified contractors capable of meeting FDA and DLA compliance. The product will be delivered in approved configurations to support readiness and medical readiness programs within the U.S. military healthcare system.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply and DeliveryThe contract entails the procurement, packaging, and delivery of DIPHENHYDRAMINE HYDROCHLORIDE INJECTION to a U.S. Navy vessel operating overseas, ensuring timely and reliable medical supply support in a deployed environment. All products must meet stringent regulatory requirements including FDA standards for pharmaceuticals and Defense Logistics Agency specifications for military-grade medical materiel, with packaging designed to withstand harsh transit conditions and maintain sterility and efficacy throughout the supply chain. The shipping terms are FOB destination, meaning the supplier assumes full responsibility for the goods until they are delivered to the vessel’s location, which underscores the importance of secure, traceable, and compliant logistics. The contract is classified as a subcontract under NAICS code 325412, relating to pharmaceutical preparation manufacturing, and is managed by the Defense Logistics Agency on behalf of the Department of Defense. Although the solicitation number and specific point of contact are not provided, the contract is accessible via the DIBBS system using the referenced award and delivery details. Compliance with all applicable military and federal regulations is mandatory, and the supplier is expected to adhere to strict quality control, documentation, and delivery timelines to support operational readiness of the deploying naval unit.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Supply of Dexamethasone Sodium Phosphate InjectionThe contract involves the procurement and delivery of 1,000 prefilled syringes of Dexamethasone Sodium Phosphate Injection, identified by NSN 6505015989257, to support military operations aboard an overseas vessel. The supplier is responsible for ensuring full regulatory compliance with military and pharmaceutical standards, including proper packaging and labeling that meets Department of Defense specifications. All materials must be manufactured, stored, and transported under controlled conditions to maintain stability and efficacy, with documentation verifying adherence to applicable quality and safety protocols. Delivery is required to a designated overseas military destination, and timelines are aligned with operational readiness needs. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing. It is managed by the Defense Logistics Agency under the Department of Defense and is tied to award SPE2DX25D9822 with delivery order SPE2D226F3064. While the solicitation details are not provided, the posting date indicates the contract was formally recorded on July 20, 2026, and the performance location is abroad without specific city or state details. The successful fulfillment of this requirement supports critical medical readiness for deployed forces and requires strict adherence to supply chain integrity and accountability standards throughout the entire lifecycle from production to final handoff.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE

Pharmaceutical Supply – Ciprofloxacin Hydrochloride and DexamethasoneThe contract entails the manufacture and supply of a sterile ophthalmic solution containing ciprofloxacin hydrochloride and dexamethasone, formulated to meet stringent quality standards set by the FDA, the Department of Defense, and current Good Manufacturing Practices. The product is intended for delivery to a U.S. Navy vessel, ensuring military personnel have access to a therapeutically validated ophthalmic treatment compliant with federal and defense-level pharmaceutical regulations. Manufacturing must consistently adhere to cGMP protocols to guarantee sterility, potency, and safety, with all processes subject to regulatory oversight to maintain compliance in a high-stakes operational environment. The contract falls under NAICS code 325412, which categorizes it within pharmaceutical and medicinal product manufacturing, and is issued under the Defense Logistics Agency, reflecting its role within the broader DoD supply chain infrastructure. Final delivery is directed to a U.S. Navy vessel, underscoring the mission-critical nature of the product in supporting the health and readiness of deployed naval forces.

Defense Logistics Agency

POSTED

about 15 hours ago

DEADLINE